Search - tctmd.com

Displaying 241 - 260 of 289

Sort: Relevancy | Date

News Daily News

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

April 20, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

Caitlin E. Cox

April 09, 2015

News Daily News

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Yael L. Maxwell

April 03, 2015

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Todd Neale

March 11, 2015

News Daily News

Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes

Yael L. Maxwell

March 04, 2015

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

News Daily News

Meta Análisis de los Beneficios Temporales del Tratamiento con Estatinas en Pacientes víctimas de SCA sometidos a PCI

March 13, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Conference News AHA 2013

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Yael L. Maxwell

November 20, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Advertisement

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Observational Studies Ask How Much Medication Adherence Matters After MI

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Post-Acute MI Survival Improving for Elderly Patients in France

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Statins More Beneficial Before PCI Than After in ACS Patients

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

Meta Análisis de los Beneficios Temporales del Tratamiento con Estatinas en Pacientes víctimas de SCA sometidos a PCI

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content